Burrill & Company of San Francisco has completed a series B round of financing of US$10 million in Bangalore-based Strand Life Sciences. Burrill is a diversified global financial services company that focuses on the life sciences industry and Strand Life Sciences develops data analysis and visualization software for microarray gene expression data.
You must be a
subscribersubscribersubscribersubscriber
to read this content, please
subscribesubscribesubscribesubscribe
today.
For group subscribers, please click here to access.
Interested in group subscription? Please contact us.